These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 39475905)
21. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions. Pereira-Vieira J; Azevedo-Silva J; Preto A; Casal M; Queirós O Biol Chem; 2019 May; 400(6):787-799. PubMed ID: 30699066 [TBL] [Abstract][Full Text] [Related]
22. CD47 Promotes Human Glioblastoma Invasion Through Activation of the PI3K/Akt Pathway. Liu X; Wu X; Wang Y; Li Y; Chen X; Yang W; Jiang L Oncol Res; 2019 Mar; 27(4):415-422. PubMed ID: 29321087 [TBL] [Abstract][Full Text] [Related]
23. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. Pértega-Gomes N; Vizcaíno JR; Miranda-Gonçalves V; Pinheiro C; Silva J; Pereira H; Monteiro P; Henrique RM; Reis RM; Lopes C; Baltazar F BMC Cancer; 2011 Jul; 11():312. PubMed ID: 21787388 [TBL] [Abstract][Full Text] [Related]
24. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival. Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974 [TBL] [Abstract][Full Text] [Related]
25. CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway. Fei F; Li X; Xu L; Li D; Zhang Z; Guo X; Yang H; Chen Z; Xing J Ann Surg Oncol; 2014 Dec; 21(13):4359-68. PubMed ID: 25084765 [TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways. Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850 [TBL] [Abstract][Full Text] [Related]
27. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
28. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway. Cheng Y; Xie P J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386 [TBL] [Abstract][Full Text] [Related]
29. Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. Hao J; Chen H; Madigan MC; Cozzi PJ; Beretov J; Xiao W; Delprado WJ; Russell PJ; Li Y Br J Cancer; 2010 Sep; 103(7):1008-18. PubMed ID: 20736947 [TBL] [Abstract][Full Text] [Related]
30. Anticancer effects of veratramine via the phosphatidylinositol-3-kinase/serine-threonine kinase/mechanistic target of rapamycin and its downstream signaling pathways in human glioblastoma cell lines. Kim D; Kwon W; Park S; Kim W; Park JK; Han JE; Cho GJ; Yun S; Han SH; Kim MO; Ryoo ZY; Choi SK Life Sci; 2022 Jan; 288():120170. PubMed ID: 34826438 [TBL] [Abstract][Full Text] [Related]
31. FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway. Zhang L; Wang H; Zhu J; Ding K; Xu J Tumour Biol; 2014 Nov; 35(11):10707-14. PubMed ID: 25070489 [TBL] [Abstract][Full Text] [Related]
32. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin. Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912 [TBL] [Abstract][Full Text] [Related]
33. Sex Hormones Regulate Rat Hepatic Monocarboxylate Transporter Expression and Membrane Trafficking. Cao J; Ng M; Felmlee MA J Pharm Pharm Sci; 2017; 20(1):435-444. PubMed ID: 29249221 [TBL] [Abstract][Full Text] [Related]
34. Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression. Voss DM; Spina R; Carter DL; Lim KS; Jeffery CJ; Bar EE Sci Rep; 2017 Jun; 7(1):4292. PubMed ID: 28655889 [TBL] [Abstract][Full Text] [Related]
35. 1α,25(OH) 2D3 Sensitive Cytosolic pH Regulation and Glycolytic Flux in Human Endometrial Ishikawa Cells. Zeng N; Zhou Y; Zhang S; Singh Y; Shi B; Salker MS; Lang F Cell Physiol Biochem; 2017; 41(2):678-688. PubMed ID: 28222424 [TBL] [Abstract][Full Text] [Related]
36. PI3K/mTORC1/2 inhibitor PQR309 inhibits proliferation and induces apoptosis in human glioblastoma cells. Yang K; Tang XJ; Xu FF; Liu JH; Tan YQ; Gao L; Sun Q; Ding X; Liu BH; Chen QX Oncol Rep; 2020 Mar; 43(3):773-782. PubMed ID: 32020210 [TBL] [Abstract][Full Text] [Related]
37. Downregulation of CD147 expression by RNA interference inhibits HT29 cell proliferation, invasion and tumorigenicity in vitro and in vivo. Li R; Pan Y; He B; Xu Y; Gao T; Song G; Sun H; Deng Q; Wang S Int J Oncol; 2013 Dec; 43(6):1885-94. PubMed ID: 24064772 [TBL] [Abstract][Full Text] [Related]
38. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). Wilson MC; Meredith D; Fox JE; Manoharan C; Davies AJ; Halestrap AP J Biol Chem; 2005 Jul; 280(29):27213-21. PubMed ID: 15917240 [TBL] [Abstract][Full Text] [Related]
39. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. Pinheiro C; Reis RM; Ricardo S; Longatto-Filho A; Schmitt F; Baltazar F J Biomed Biotechnol; 2010; 2010():427694. PubMed ID: 20454640 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A. Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]